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Summary 
Rearrangement of the immunoglobulin (lg) and T  cell receptor (TCR) gene loci allows for the 
generation of B and T  lymphocytes with antigen-specific receptors. Complete rearrangement 
and expression of the  TCtL-[3  chain  enables immature thymocytes to  differentiate from the 
CD4-CD8- to the CD4+CD8 + stage. Mice in which rearrangement is impaired, such as severe 
combined immunodeficient (SCID) mice or recombinase activating gene-deficient (RAG -/-) 
mice,  lack  mature  B  and  T  lymphocytes. Thymocytes from these  mice  are  arrested  at  the 
CD4-CD8-  stage  of T  cell  development.  We  previously  observed  that  thymocytes  from 
RAG-2 -/-  mice  exposed  to  "y  radiation  differentiate  from  CD4-CD8-  into  CD4+CD8 + 
without TCR-[3 chain rearrangement. We now report that irradiated RAG-2 -/- thymocytes 
undergo direct somatic mutations at the p53 gene locus, and that p53 inactivation is associated 
with maturation of RAG-2 -/- thymocytes to the CD4+CD8 + stage. Generation of RAG-2 -/- 
and p53 -/-  double-deficient mice revealed that,  in the absence of TCR-[3 chain rearrange- 
ment, loss  of p53  function  is sufficient for CD4-CD8-  thymocytes to  differentiate into  the 
CD4*CD8 + stage ofT cell development. Our data provide evidence for a novel p53-mediated 
checkpoint in early thymocyte development that regulates the transition  of CD4-CD8-  into 
CD4+CD8 + thymocytes. 
A 
daptive immunity requires the establishment of a large 
repertoire of lymphocytes, each beating a unique anu- 
gen-specific receptor. Successful rearrangement ofTCtL gene 
loci is necessary for proper thymocyte development and for 
the generation of a mature T  cell repertoire. Mice with re- 
combination deficiencies, such as SCID and RAG -/-, dis- 
play a differenuation arrest early in T  cell development and 
lack  receptor-beating  T  cells  in  the  periphery  (l-3).  In 
these mice, thymocyte development does not proceed fur- 
ther  than  the  early immature  CD4-CD8-  (double-nega- 
tive, DN) stage. Recent evidence supports the notion that 
signals  derived from a pre-To~ chain and a fully rearranged 
TCIL-[3 chain at the DN stage drive thymocyte differentia- 
tion  to  the  next  point  in  development,  the  CD4+CD8 + 
(double-positive,  DP)  stage  (4-6).  This  TCP,.-[3  chain- 
mediated differentiation event has  been termed  "[3  selec- 
tion" (6-8). Once thymocytes reach the DP stage, TCR-ot 
chain rearrangement occurs, allowing for the TCR-MHC 
interactions that result an the negative or positive selecuon 
of developmg thymocytes (9,  10). 
We recently reported that DN thymocytes from RAG- 
2 -/-  mice differentiate into DP thymocytes after exposure 
to ~  radiauon,  and that this induced  differentiation occurs 
in the absence of TCR-[3 rearrangement (1l).  Because of 
their inability to recombine their TCR gene loci, DN thy- 
mocytes  from RAG-2 -/-  mice  have  a  limited  develop- 
mental potential and a shortened fife span (4, 7). This lim- 
ited  life  span  may  reflect  a  dominant  programmed  cell 
death  (apoptosis)  pathway  that  is  normally suppressed by 
TCP~-[3 signals.  We hypothesized that thymocytes from ir- 
radiated RAG-2 -/-  mice acquire  a  novel phenotype that 
permats them to proceed with thymocyte development by 
superseding  the  required  TCIL-[3  differentiation  signals. 
DP thymocytes induced by radiation may have failed to re- 
spond to  the  appropriate death signals  that DN cells  nor- 
mally receive in the absence of TCR-[3 selection.  To ad- 
dress this possibxlity,  we investigated genes involved m  the 
apoptosis  pathway  that  may  be  responsible  for  inducing 
death  of DN  thymocytes  that  fail  to  rearrange  TCR-[3 
gene loci. 
One of the key regulatory genes involved in the induc- 
tion  of apoptosis is p53  (12).  Cells with  mutant  forms of 
p53  are  resistant  to  several inducers  of apoptosis,  such  as 
DNA damage (12,  13).  This is most evident in the prepon- 
derance of human tumors known to have a mutated form 
of the p53 gene, which is thought to lead to a deregulated 
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contains  several  regions,  known  as  "hot  spots,"  that  are 
highly susceptible  to direct somatic mutations from expo- 
sure to radiation or DNA-damaging agents (15).  In this re- 
port, we show that irradiated RAG-2 -/- thymocytes acquire 
radiation-induced somatic mutations of the p53 gene, which 
can enable  DN thymocytes to advance to the DP stage m 
the absence of TCtL-I3 survival/differentiation  signals.  We 
directly demonstrate  the  involvement of p53 during DN- 
to-DP thymocytes differentiation by showing that DN thy- 
mocytes differentiate to the DP stage ofT cell development 
in tLAG-2-/-/p53 -/- double-deficient mice. Thus, in the 
absence of TCR-I3 chain rearrangement,  loss of p53 func- 
tion  is  sufficient  for  the  transition  of CD4-CD8-  into 
CD4+CD8 + thymocytes. 
Materials and Methods 
Mice.  RAG-2  -/-  mice  were  obtained  from  Dr.  Fred  Alt 
(Howard Hughes Medical  Institute,  Children's Hospital,  Boston, 
MA)  (2)  and  bred  in  our animal  facility,  p53 -/-  mice  were 
purchased from Tacomc Farms,  Inc. (Germantown, NY). Dou- 
ble-deficient  p53-"-/RAG-2-"-  trace  were  bred  in  our facility. 
Double-mutation homozygosity was determined by flow cytome- 
try analysis for  RAG-2-"-  phenotype  or by PCR  analysis for 
p53-'- genotype. Adult p53-/-/RAG-2 -'- mice (10-12 wk) were 
used for the flow cytometry analysis shown in Fag. 3; before analy- 
sis, mace were checked for the absence  of any overt tumors. All 
other mice  were  obtained  from the  National  Cancer  Institute, 
Frederick Cancer Research and Development Center (Frederick, 
MD). lrradianon of  mace was performed as prevmusly described (16). 
Flow Cytometry.  Antibodies for flow cytometry were purchased 
from PharMingen (San Diego, CA). Staining ofceUs was performed 
as previously described  (16). 
RNA and PCR Analysis.  Total RNA from thymocytes was pre- 
pared wath tLNAzol (Tel-Test Inc.,  Friendswood, TX)  as indi- 
cated by the manufacturer.  Reverse transcriptase (P,T)-PCR. analy- 
sis and cloning of  p53 were performed using standard techmques. 
I/riefly,  P,.T reactions  were performed with isolated  RNA from 
thymocytes of control or 2-wk postirradiation  RAG-2  -/-  mice 
using random hexamer primers.  The first-strand  cDNA products 
were  amphfied by PCR  using pfu DNA polymerase with p53 
gene-speclfic  primers  (5'  CCT  GTC  ATC  TTT  TGT  CCC 
TTC TCA 3', for the upper primer at position 424, and 5' ATA 
AGA  CAG  CAA  GGA  GAG  GGG  GAG  3',  for  the  lower 
primer at position 1361). The PCR_ product was analyzed by gel 
electrophoresis  or cloned using the T/A cloning system (lnvitro- 
gen, San Diego, CA). Plasmids containing the p53 gene were se- 
quenced with several gene-specific  primers using the Sequenase 
2.0 system (Amersham Corp., Arlington Heights, IL). 
Immunoprecipitation and Western Blot Analysis.  Thymocyte nu- 
clear extracts were prepared as previously described (17). Nuclear 
extracts  were lmmunoprecipltated  with  either Pab-246 or Pab- 
240 mAb (Santa Cruz Biotechnology Inc., Santa  Cruz, CA) for 
the wild-type or mutant forms of p53, respecuvely.  SDS-PAGE 
was performed on immunoprecipltated material  and electroblot- 
ted onto nitrocellulose  membranes.  Immunoblots were hybrid- 
ized using Pab-240 mAb, which recognizes both wild-type and 
mutant  forms  of denatured/membrane-bound  p53. Polyclonal 
antl-mouse-K/h-HRP-labeled  lg (Southern  Biotechnology As- 
sociates, Barmingham,  AL) was used to detect the hybridizing an- 
ubody. The ECL system  (Amersham Corp.)  was used  to detect 
the secondary antibody. 
Results and Discussion 
Thymocytes from recombination-deficient  (RAG-2-'-) 
mice are blocked at  the  DN  stage  of T  cell  development 
(Fig.  1).  Thymocytes  from  RAG-2  -/-  mice  exposed  to 
sublethal  doses  of ~/radiation  show the  appearance  of DP 
cells  2  wk after treatment  (Fig.  1).  SurpnsingJy,  DN  thy- 
mocytes reach  the DP stage in  the  absence of TCI< gene 
rearrangement  (11,  18). This finding provides evidence for 
a  DN-to-DP  differentiation  event  independent  of rear- 
ranged  TCR-I3  chain  and  pre-Tc~  signals.  Thus,  thymo- 
cytes from irradiated RAG-2 -/-  mice must overcome the 
requirement for survival/differentiation signals normally pro- 
vided by TCIL-I3 and pre--Ta  chains  (4-6).  We hypothe- 
sized that "y radiation may be affecting genes that normally 
control cell death or survival events during thymocyte de- 
velopment. Therefore, we investigated the potential role of 
p53 in the generation of DP ceils  in irradiated  RAG-2 -~- 
mice. We chose p53 as a candidate gene because of its  in- 
volvement in controlling ceil cycle and apoptosis after ex- 
posure  to  DNA-damaging  agents  (12-14).  Furthermore, 
p53 has been shown to readily undergo somatic mutation 
m  cells after exposure to radiation (15). 
We isolated mR.NA from normal RAG-2 -/- thymocytes 
or from RAG-2 -/- thymocytes 2 wk after irradiation  (IR- 
tLADRAG;  8.5  Gy).  After  RT  with  random  hexamer 
primers,  PCR with gene-speclfic primers was used to am- 
plify mRNA  transcripts from the p53 gene. The RT-PCR 
product was generated using Pfu polymerase to avoid PCR- 
mediated errors in the DNA sequence. The RT-PCR  pro- 
duct was cloned, and plasmids containing p53 from several 
different  colomes were sequenced.  The p53 sequence  de- 
rived from normal RAG  thymocytes was  identical  to  the 
previously reported sequence  (12). By contrast, several p53 
gene  sequences  derived  from irradiated  RAG  thymocytes 
revealed various nucleotide changes that would result in an 
altered p53 protein (Table  1). Thus, thymocytes that devel- 
oped 2  wk  after  radiation  exposure  may express  mutated 
p53  genes.  However,  not  all  of the p53  cDNAs  derived 
from irradiated thymocytes showed genetic alterations.  This 
may be due to the use of total thymus rather than isolated 
DP thymocytes to prepare the mRNA.  Nonetheless,  mu- 
tated cDNAs of p53 were obtained :n 42% of the colonies 
we  analyzed from irradiated  thymuses but  in none  of the 
thymuses  from nonirradiated  RAG-2 -/-  mice  (Table  1). 
These  findings  demonstrated  that  treatment  with y  radia- 
tion can directly mutate the p53 gene. 
Our analysis of p53 protein expression revealed the pres- 
ence of mutant forms of p53 in thymocytes from irradiated 
RAG-2 -/-  but not from control RAG-2  -/-  mice.  Fig.  2 
shows a  Western  blot analysis of immunoprecipitated p53 
from irradiated  or control  RAG-2 -/-  thymocyte nuclear 
extracts using wild-type or mutant form-specific mAbs. As 
a positive control for the immunoprecipitation  and West- 
ern  blot,  we  used  nuclear extracts  from A43l  cells  (Santa 
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Figure 1.  Two-parameter flow cytometry analysis of 
thymocytes  from  C57Bl/6,  RAG-2  -/-  rmce, and 
R.AG-2  -/- mice 2 wk after sublethal (750 cGy)  ~/lrra- 
diataon (IRRADRAG). Thymocyte single-cell suspen- 
sions were  stained with  CD8-FITC versus CD4-PE 
and analyzed  by flow cytometry. Propldium iodide was 
used  to  exclude dead cells from  the  analysis. Data 
shown are representanve of >10 independent FACS  | 
analyses. 
Cruz Biotechnology), which express a mutant form of p53 
(19)  (data not shown). Consistent with our DNA sequence 
analysis, the immunoblot shows that thymocytes from irra- 
diated RAG-2 -/-  mice express mutant and wild-type p53. 
Thus,  our analysis  provides  direct  evidence  that  exposure 
to radiation can cause the emergence of a cell population in 
which the p53 gene is mutated and an altered p53 protein 
is  expressed.  Therefore,  we hypothesized  that mutant p53 
may allow  DN  thymocytes from RAG-2  -/-  mice  to  es- 
cape apoptosis and progress to the DP stage. 
To test the participation of p53 in the prevention of DP 
thymocyte  differentiation  in  RAG-2  -/-  mice,  we  bred 
RAG-2  -/-  mice  with  p53-deficient  mice  (p53-/-).  Al- 
though  T  cell  development  appears  to  occur  normally  in 
p53 -/- mice (20), thymocytes from these mice are resistant 
to  certain  forms  of induced  programmed  cell  death  (20). 
Analysis ofthymocytes from p 5  3- /- /RA  G-2 -/- (p  5  3  /RAG) 
mice demonstrated the presence of CD4+CD8 + thymocytes 
(Fig.  3),  whereas  thymic  cellularity  did  not  increase  by 
>50% from that observed in RAG-2  -/-  mice (1-3  ￿  106 
cells/thymus). Further analysis  showed that the emergence of 
DP cells is  not simply an aberrant  expression  of CD4 and 
CD8,  but  rather  a  progression  to  the  next  differentiation 
stage (7).  Fig. 3 shows that, in several aspects of their devel- 
opmental status,  the new population  of DP thymocytes in 
p53/RAG mice displayed a phenotype normally associated 
with the CD4+CD8 + stage of development, including loss 
Table  1.  p53 Mutations in RAG-2 -/- Thymocytes after  Sublethal 
T Radiation 
Nucleotide  Codon  Amino acid 
Clone  change  locataon  change 
Clone 2  CAG-->TAG  164  gln-->stop 
Clone 10  ATC-->GTC  157  ile-->val 
Clone 6  TAC-->TTC  160  tyr-->phe 
Clone 6  ATG-->ATT  165  met-->ile 
Clone 6  CGC-->TGC  175  arg-->cys 
Clone 5  TCT-->CCT  124  ser-->pro 
Clone D2  AAC-->AGC  237  ser-->asn 
Mutation  frequency in p53  cDNAs from ~rra&ated RAG-2-/- thy- 
mocytes is  42% (5/12),  and from thymocytes of control  RAG-2 -/- 
mice is 0% (6/6). 
oflL-2R expression, decreased MHC class I expression, and 
smaller  cell  size  (Fig.  3,  a-d)  (11).  We  failed  to  detect 
TCR-I3  chain  rearrangement  or cell  surface  expression  of 
CD3 on DP thymocytes from p53/RAG mice (Fig. 3 e and 
data  not shown).  Therefore,  lack of p53  function is  suffi- 
cient  to  allow for the  differentiation  of CD4-CD8-  into 
CD4~CD8 + thyrnocytes in RAG-2  -/- mice in the absence 
of TCR  rearrangement.  Although DP thymocytes develop 
in p53/RAG  mice,  the  lack  of TCR-a/13  rearrangement 
and  expression  precludes  positive  selection  on  self-MHC 
from occurring and prevents further thymocyte differentia- 
tion.  Thus,  positive  selection  of CD4+CD8 -  and  CD4- 
CD8 §  thymocytes is apparently controlled by a p53-inde- 
pendent pathway. 
DP thymocyte differentiation  normally requires  the  ex- 
pression of a rearranged TCR-I3 chain and a monomorphic 
pre-Tc~  chain  (4-8).  Developing  thymocytes  that  fail  to 
properly rearrange their TCR-[3 loci undergo programmed 
cell  death  (7).  This  phenotype  is  most  apparent  in  SCID 
and RAG -/- mace. The mechanism by which DN thymo- 
cytes without TCR  are prevented from further maturation 
is not understood. We propose that p53 is involved in the 
regulatory pathway that directs TCR-  DN  thymocytes to 
undergo apoptosis. In the absence of p53 control, TCR-  DN 
thymocytes are  free  to  enter  the  next  stage  of thymocyte 
differentiation.  While  in  the  presence  of functional p53, 
DN thymocytes require differentiation/survival signals pro- 
vided  by the  TCR-I3  chain.  There  is  strong  evidence  to 
suggest  that  the  signals  delivered  by the  TCIL-I3 chain to 
DN cells are mediated by the protein tyrosine kinase p56  ~k 
(21-24).  This  is  evident  from  reports  that  show  reduced 
numbers  of DP  cells  present  in  kk  -/-  mice  (21,  22)  and 
from findings that show the appearance of  DP cells in trans- 
genic RAG-' -  mice expressing a constitutively active form 
Figure  2.  lmmunoprecipltauon and 
Western  blot  analysis for  wild-type 
and mutant forms of p53. Nuclear ex- 
tracts from  control  RAG-2-'-  thy- 
mocytes and IRRADRAG thymocytes 
(2 wk after exposure to 750 cGy) were 
mmmnoprecapltated  with specific  mAbs 
for the wild-type or mutant forms of 
p53  (Pab-246 or  Pab-240 mAb, re- 
specnvely)  Immunoblots  of  SDS- 
PAGE-lmmunopreclpltated  material 
were performed with Pab-240 mAb. 
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Figure 3.  Two-parameter flow cytometry analy- 
sis of thymocytes from C57B1/6, R.AG-2- -mtce. 
or  from  double-deficient RAG-2-'-  X  p53-- 
mace (>8 wk old). Thymocyte single-cell suspen- 
stuns were stained wath (a)  CD8-FITC  versus 
CD4-PE,  (b)  IL-2Re~-FITC versus CD4-PE,  (c) 
MHC-Kb-FITC versus CD4-PE, (d) forward side 
scatter (FSC), and (e) TCR-~x/i3-FITC for FACS  ~ 
analysts, as re&cared. 
of lck (23).  Furthermore,  the ability to generate DP cells in 
RAG -/.  mice treated  with anti-CD3~  mAb was recently 
shown to involve Ick-mediated  signals (24). 
TCR-~  chain Ick-derived  signals in DN cells  may influ- 
ence the survival potential of DN cells by activating the bd- 
2  gene and/or by preventing p53-mediated  apoptosas.  In- 
volvement of the bd-2 survival-promoting oncogene at the 
DN-to-DP  transition  stage  was  shown  by  the  abihty  to 
generate DP cells in bd-2-transgenic  RAG-1-/-  mace (25). 
Thus m  the absence ofTCR-I3 (Ick) sagnals,  bcl-2 was suffi- 
ctent to block apoptosls and allow DN cells to differentiate 
to the DP stage (25).  Importantly, the bd-2 survival signals 
can be countered by the bax gene (26-28).  In this context, 
tt is interesting that p53 has been shown to promote apop- 
tosis by repressing bcl-2 expression and by upregulatmg bax 
transcription  (29,  30).  Taken  together  wath  our  findings, 
we suggest that the progression to the DP stage in the ab- 
sence of TC1L-[~ can be normally prevented by a p53-reg- 
ulated  programmed  cell  death  pathway.  TCR-[3/pre-To~ 
chains  most  likely  coordinate  the  signals  that  lead  to  the 
survival  of DN  cells  to  the  DP  stage  by  mediating  lck- 
derived signals and regulating bd-2/bax activanon and p53 
inactivation in order to allow further thyrnic differentiation 
to proceed unhampered. 
Although  thymocyte development  in  RAG -/-  mice  is 
blocked at the DN stage, stx different experimental  manip- 
ulations in RAG-"-  mice show that this impediment can be 
overcome: (a) transgemc expression of a rearranged TCR-~3 
chain  (4);  (b)  antl-CD3  mAb treatment  (24);  (c) transgenxc 
expression  of a constitutively active lck (23);  (d)  transgenic 
1926  p53 m Thymocyte D~fferennatlon overexpression of bd-2 (25);  (e) sublethal ~/radiation treat- 
ment (11,  18); and (.D inactivation of the p53 gene (this re- 
port). In the first three settings, DP thymocyte differentiation 
results from Ick-mediated signals, which allow DN  thymo- 
cytes to differentiate and expand (up to a  100-fold increase 
in thymic cellularity) into the next stage. Thus, positive sig- 
nals from lck drive differentiation and proliferation. In the 
last three settings, DP thymocyte differentiation is observed 
without a  dramatic increase in thymic cellularity. In these 
situations, where the programmed cell death pathway is in- 
hibited, differentiation withotit proliferation into DP stage 
is observed. Therefore, DN-to-DP thymocyte differentiation 
can  occur  in  the  absence  of proliferation, and  these  pro- 
cesses are molecularly distinct. Thus, TCR-I3 selection may 
achieve  two  critical functions,  differentiation and  thymo- 
cyte expansion, in causing the emergence ofDP thymocytes. 
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